Cancer Screening in Women

Main Article Content

Achjima Tankul
Irene Ruengkhachorna

Abstract

Cancer is the leading cause of death in Thai. Cancer screening is the major strategy for cancer prevention and early detection, leading to a decrease in cancer - related mortality rate. The effective cancer screening program in women are cervical cancer, breast cancer, colorectal cancer, and lung cancer. Tests that have been investigated as potential screening methods for ovarian cancer and endometrial cancer are unsatisfactory. The best cost-utility of cancer screening program in Thailand should be further investigated.


 

Article Details

How to Cite
1.
Tankul A, Ruengkhachorna I. Cancer Screening in Women. Rama Med J [Internet]. 2017 Jan. 6 [cited 2024 Mar. 29];39(4):256-63. Available from: https://he02.tci-thaijo.org/index.php/ramajournal/article/view/80471
Section
Original Articles

References

World Health Organization, International Agency for Research on Cancer (IARC). GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence wordwide in 2012. Available from: http://globocan.iarc.fr/Page/fact_sheets_cancer.aspx. Accessed November 15, 2015.

Attasara P, Sriplung H. Cancer incidence in Thailand. In: Khuhaprema T, Attasara P, Sriplung H, Wiangnon S, Sangrajrang S, editors. Cancer in Thailand. Bangkok: Lyon: International Agency for Research on Cancer; 2013. p. 8-76.

Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M, et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis. 2013;(5 Suppl 1):S1-S27.

Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M, et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol. 2013;121:829-46.

The Royal Thai College of Obstetricians and Gynaecologists Website. Available from: http://www.rtcog.or.th/html/photo/articlesfile_905957.pdf. Accessed November 15, 2015.

Department of Health Website. Available from: http://www.anamai.moph.go.th/ewt_news.php?nid=7023. Accessed November 15, 2015.

van Nagell JR, Jr., Hoff JT. Transvaginal ultrasonography in ovarian cancer screening: current perspectives. Int J Womens Health. 2013;6:25-33.

van Nagell JR, Jr., Miller RW, DeSimone CP, Ueland FR, Podzielinski I, Goodrich ST, et al. Long-term survival of women with epithelial ovarian cancer detected by ultrasonographic screening. Obstet Gynecol. 2011;118:1212-21.

Kobayashi H, Yamada Y, Sado T, Sakata M, Yoshida S, Kawaguchi R, et al. A randomized study of screening for ovarian cancer: a multicenter study in Japan. Int J Gynecol Cancer. 2008;18:414-20.

Buys SS, Partridge E, Greene MH, Prorok PC, Reding D, Riley TL, et al. Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial. Am J Obstet Gynecol. 2005;193:1630-9.

Menon U, Gentry-Maharaj A, Hallett R, Ryan A, Burnell M, Sharma A, et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol. 2009 Apr;10(4):327-40.

Menon U, Griffin M, Gentry-Maharaj A. Ovarian cancer screening--current status, future directions. Gynecol Oncol. 2014;132:490-5.

Menon U, Kalsi J, Jacobs I. The UKCTOCS experience--reasons for hope? Int J Gynecol Cancer. 2012;22 (Suppl 1):S18-20.

Rosenthal AN. Ovarian cancer screening in the high-risk population--the UK Familial Ovarian Cancer Screening Study (UKFOCSS). Int J Gynecol Cancer. 2012;22 (Suppl 1):S27-8.

Smith RA, Manassaram-Baptiste D, Brooks D, Doroshenk M, Fedewa S, Saslow D, et al. Cancer screening in the United States, 2015: a review of current American cancer society guidelines and current issues in cancer screening. CA Cancer J Clin 2015;65:30-54.

Wilt TJ, Harris RP, Qaseem A. Screening for cancer: advice for high-value care from the American College of Physicians. Ann Intern Med. 2015;162:718-25.

Viguier J, Morere JF, Touboul C, Coscas Y, Blay JY, Lhomel C, et al. Cancer screening in France: third edition of the EDIFICE survey. Eur J Cancer Prev. 2015;24 Suppl:S68-72.

Committee opinion no 609: colorectal cancer screening strategies. Obstet Gynecol. 2014;124:849-55.